SOFW SOFWAVE MEDICAL LTD

Sofwave to Participate in Upcoming Conferences

Sofwave to Participate in Upcoming Conferences

SAN CLEMENTE, Calif., March 26, 2025 (GLOBE NEWSWIRE) -- Sofwave Medical Ltd (“the Company”) (TASE: SOFW), an emerging leader in energy-based non-invasive, aesthetic medical devices, today announced that Louis Scafuri, Chief Executive Officer, and Assaf Korner, Chief Financial Officer, will participate in the following conferences:

24th Annual Needham Virtual Healthcare Conference

Presentation Format: Corporate overview

Presentation Date: Wednesday, April 9, 2025

Presentation Time: 9:30 a.m. ET

Webcast:

Wells Fargo 2025 Virtual Private MedTech Symposium

Format: 1x1 meetings only

Date: Wednesday, April 9, 2025

About Sofwave Medical

 has implemented an innovative approach to wrinkle reduction lifting and cellulite using its proprietary breakthrough technology. SUPERB™, Synchronous Ultrasound Parallel Beam technology, is FDA-cleared to improve facial lines and wrinkles, lifting the eyebrow and lifting lax submental tissue (beneath the chin), to improve the appearance of skin laxity on the upper arms, as well as the short-term improvement in the appearance of cellulite and treatment of acne scars. The company’s Pure Impact™ module uses 4th generation EMS technology and is cleared for muscle toning. Sofwave’s products provide physicians with smart yet simple, effective, and safe aesthetic solutions for their patients. Contact: 

Investor Contact:

Brian Ritchie

LifeSci Advisors LLC

(212) 915-2578



EN
26/03/2025

Underlying

SOFWSOFWAVE MEDICAL LTD

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on SOFWAVE MEDICAL LTD

 PRESS RELEASE
Free
SOFW SOFWAVE MEDICAL...

Sofwave’s liftHD Body Contouring Applicator to Debut at the 44th Annua...

Sofwave’s liftHD Body Contouring Applicator to Debut at the 44th Annual Meeting of the American Society for Laser Medicine and Surgery (ASLMS) 2025 Launch of the liftHD body applicator provides opportunity for next generation non-invasive aesthetic body treatments which improve cellulite and skin laxity appearance in order to achieve SUPERB results beyond the face Four abstract poster presentations highlighting clinical applications and results of Sofwave’s SUPERB™ non-invasive medical aesthetic technology will also be on exhibit SAN CLEMENTE, Calif., April 24, 2025 (GLOBE NEWSWIRE) -- ...

April 24, 2025 1 EN
 PRESS RELEASE
Free
SOFW SOFWAVE MEDICAL...

Sofwave’s SUPERB™ Non-Invasive Skin Treatment Technology Receives Regu...

Sofwave’s SUPERB™ Non-Invasive Skin Treatment Technology Receives Regulatory Clearance in Japan Significantly Expanding its Coverage of the APAC Region Japan represents third largest non-surgical medical aesthetic market in the world SAN CLEMENTE, Calif., April 21, 2025 (GLOBE NEWSWIRE) -- Sofwave Medical Ltd (“the Company”) (TASE: SOFW), an emerging leader in energy-based non-invasive, aesthetic medical devices, today announced that Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) has granted the Company approval to commercially market Sofwave’s SUPERB™ Technology. Market appr...

April 21, 2025 1 EN
 PRESS RELEASE
Free
SOFW SOFWAVE MEDICAL...

Sofwave to Participate in Upcoming Conferences

Sofwave to Participate in Upcoming Conferences SAN CLEMENTE, Calif., March 26, 2025 (GLOBE NEWSWIRE) -- Sofwave Medical Ltd (“the Company”) (TASE: SOFW), an emerging leader in energy-based non-invasive, aesthetic medical devices, today announced that Louis Scafuri, Chief Executive Officer, and Assaf Korner, Chief Financial Officer, will participate in the following conferences: 24th Annual Needham Virtual Healthcare ConferencePresentation Format: Corporate overviewPresentation Date: Wednesday, April 9, 2025Presentation Time: 9:30 a.m. ETWebcast: Wells Fargo 2025 Virtual Private MedTech...

March 26, 2025 1 EN
 PRESS RELEASE
Free
SOFW SOFWAVE MEDICAL...

Sofwave Medical Reports Fourth Quarter and Full Year 2024 Financial Re...

Sofwave Medical Reports Fourth Quarter and Full Year 2024 Financial Results and Business Highlights – Fourth quarter revenue of $18.3M, +20% year-over-year growth; IFRS gross margin of 77.0% – Full fiscal 2024 revenue of $59.7M, +19% year-over-year growth; IFRS gross margin of 76.0% – Full fiscal 2024 pulse recurring revenue of $23.3M, +79% year-over-year growth – Nearing breakeven, as IFRS operating loss narrowed to -$0.1M in the fourth quarter; generated non-IFRS fourth quarter operating profit of $0.6M SAN CLEMENTE, Calif., March 05, 2025 (GLOBE NEWSWIRE) -- Sofwave Medical Ltd (TA...

March 5, 2025 1 EN
 PRESS RELEASE
Free
SOFW SOFWAVE MEDICAL...

Sofwave Medical Reports Preliminary Unaudited Fourth Quarter and Full ...

Sofwave Medical Reports Preliminary Unaudited Fourth Quarter and Full Fiscal Year 2024 Topline Financial Results SAN CLEMENTE, Calif., Jan. 13, 2025 (GLOBE NEWSWIRE) -- Sofwave Medical Ltd (TASE: SOFW), an emerging leader in energy-based non-invasive, aesthetic medical devices for practitioners worldwide, reports preliminary financial results for the fourth quarter and full fiscal year, for the period ended December 31, 2024. Preliminary financial results Fourth quarter 2024 revenue is expected to total between $18.2 million and $18.4 million, as compared to approximately $15.3 million ...

January 13, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch